| 期刊全稱 | ACEi and ARBS in Hypertension and Heart Failure | | 影響因子2023 | Pasquale Perrone Filardi | | 視頻video | http://file.papertrans.cn/143/142675/142675.mp4 | | 發(fā)行地址 | Presents highly practical information on the appropriate use of RAS antagonists in cardiovascular diseases.Emphasis is on a just-the-facts clinical approach.Describes clinical indications of ACEi and | | 學(xué)科分類 | Current Cardiovascular Therapy | | 圖書封面 |  | | 影響因子 | The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic, written in a quick-access, no-nonsense format. The emphasis will be on a just-the-facts clinical approach, heavy on tabular material, light on dense prose.?The involvement of the ISCP will ensure that the best quality contributors will be involved and establish a consistent approach to each topic in the series and this title is no exception. It will contain practical illustrations and is designed to improve understand and practical usage of cardiovascular drugs in specific clinical areas. | | Pindex | Book 2015 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-6 12:44
發(fā)表于 2025-3-21 19:55:53
